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strains with de novo resistance. Hence, the ﬁndings obtained
in the present study suggest that the rpsL K43R mutation in
STR-resistant M. tuberculosis may not occur independently
and randomly in different genotype strains. Instead, it is
genotype-related (i.e. the Beijing genotype has a particular
propensity to acquire the rpsL K43R mutation) and this
molecular mechanism may account for the high frequency of
Beijing strains among STR-resistant isolates.
In conclusion, the high frequency of mutations in rpsL and
rrs in STR-resistant isolates from Singapore suggests that tar-
geted mutation screening could be feasible for the rapid
determination of STR resistance. Furthermore, the present
study provides evidence of the association between the rpsL
K43R mutation and STR-resistant strains of the Beijing geno-
type. Further studies to determine whether Beijing strains
with the rpsL K43R mutation have increased transmissibility
and/or virulence are warranted.
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Abstract
Necrotizing fasciitis due to methicillin-resistant Staphylococcus
aureus (MRSA) is an uncommon but life-threatening infection,
and has mainly been reported as occurring in adults and the
elderly. Recently, infant cases involving Panton–Valentine
leukocidin (PVL)-positive community-acquired MRSA have been
noted. Here, a case of fatal necrotizing fasciitis with sepsis and
disseminated intravascular coagulation in an extremely low-birth-
weight infant is described. The causative agent was the hospital-
acquired MRSA New York/Japan clone carrying the spa variant
gene and nine staphylococcal enterotoxin (SE) genes. These data
suggest that a high-level combination of SEs and other virulence
factors, but not PVL, could contribute to the pathogenesis of
fatal necrotizing fasciitis.
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Necrotizing fasciitis is an uncommon but life-threatening
infection, in which progressive necrosis occurs in superﬁcial
fascia and adjacent subcutaneous tissue [1]. Mortality rates
reach 6–76% [1,2]. It is often polymicrobial (including Staphy-
lococcus aureus) but not always [3].
Methicillin-resistant S. aureus (MRSA) has been a major
cause of nosocomial infections since 1961 [4] and commu-
nity-acquired MRSA has recently emerged [5], causing skin
and soft-tissue infections [5], and often producing Panton–
Valentine leukocidin (PVL) [6]. Here, a fatal case of MRSA-
caused necrotizing fasciitis in an extremely low-birth-weight
(ELBW) infant is described, as well as the molecular charac-
teristics of the MRSA isolate.
An ELBW (652 g) infant born at 24 weeks and 2 days of
gestation was transferred to the neonatal intensive care unit
of a hospital just after delivery, and placed under artiﬁcial
respiratory management. The blood pressure and urine
volume decreased from days 0 to 7 after birth. Vasopressin
administration was initiated on day 6 after birth, in addition
to hydrocortisol. Hyperkalaemia persisted, with oliguria, for
which glucose insulin (GI) treatment was continued until
day 6. Intracranial haemorrhage was detected by transcranial
ultrasound examination on day 2, and resolved by blood
transfusion on day 5. Although the patent ductus arteriosus
became symptomatic on day 4, indomethacin treatment was
postponed until haemostasis of the intracranial haemorrhage
on day 8, and the duct was closed on day 10. Ampicillin
venous injection was initiated when C-reactive protein (CRP)
levels rose slightly (0.15 mg/dL) on day 10. CRP levels further
rose to 2.5 mg/dL on day 11, and sepsis was suspected. Ami-
kacin was additionally administered, but leucocyte and platelet
counts decreased (5500/mL and 1.6 · l04/mL, respectively)
on day 12, suggesting complication by disseminated intravas-
cular coagulation (DIC), for which granulocyte-colony stimu-
lating factor (G-CSF) and gabexate mesylate administration
was initiated. Discoloration of the patient’s right leg occurred
within 12 h. The discoloration (purple) of the skin was ﬁrst
noticed below the ankle around the area of percutaneous
central venous catheter insertion for venous infusion (day
11), and rapidly spread to the proximal part of the right
extremity. Careful examination of the right leg after removal
of the catheter revealed that the point of catheter insertion
was black due to necrosis of the skin. Hyperkalaemia
occurred again on day 12, and GI treatment was reinstated.
On day 12, MRSA was detected upon culture of blood and the
right leg necrotic region, and the antimicrobial treatment was
switched to panipenem and vancomycin. Wide QRS and ven-
tricular arrhythmia were observed upon electrocardiography
on day 13. The blood pressure fell and bradycardia appeared,
and the patient died in the evening of the same day.
Molecular typing of MRSA was performed as described
previously [7]. Multi-locus sequence typing was conducted
using seven housekeeping genes. The spa type was analysed
by sequencing of the PCR product of the spa gene [encoding
for Spa (protein A)]. Detection of the accessory gene regula-
tor (agr) allele group was according to PCR. The staphylo-
coccal cassette chromosome mec (SCCmec) types (I–V)
were analysed by PCR. Coagulase typing was conducted
using a staphylococcal coagulase antiserum kit (Denka Seiken,
Tokyo, Japan). Analysis of the virulence genes (three leukoci-
din genes including the PVL gene, ﬁve haemolysin genes, 17
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staphylococcal enterotoxin (SE) genes, one putative SE gene,
three exfoliative toxin genes, and 14 adhesin genes) was
according to PCR. Susceptibility testing of bacterial strains
was carried out using the agar dilution method according
to previous procedures [7]. Antimicrobial agents included
oxacillin, gentamicin, kanamycin, arbekacin, vancomycin,
teicoplanin, linezolid, tetracycline, minocyclin, erythromycin,
clindamycin, levoﬂoxacin, fosfomycin, trimethoprim, sulfamth-
oxazole, fusidic acid, rifampicin, and mupirocin.
The molecular characteristics of the isolated MRSA (strain
NN33) are summarized in Table 1. It belonged to ST5 and
exhibited spa387, agr2, SCCmecII, and coagulase type II, indi-
cating a spa variant (spa387) of the New York/Japan clone
[7–9,12]. The sequence of the spa gene of strain NN33 (Gen-
Bank accession no. AB467285) demonstrated a shorter stem
region (short sequence repeat) than the stem region of spa2
MRSA strains. Regarding other virulence genes, strain NN33
was negative for the PVL gene, but positive for the entero-
toxin gene cluster (egc) carrying seg, sei, sem, sen, and seo, as
the New York/Japan clone [7,12]. Moreover, it carried the
superantigen-encoding pathogenicity island (SaPIm1/n1), pos-
sessing the genes tst [which codes for toxic shock syndrome
toxin 1 (TSST-1)], sec and sel, as the Japanese type of
the New York/Japan clone [7,9]. Strain NN33 was also
positive for the sep gene, and was multiple-drug resistant
(Table 1).
Although patients with necrotizing fasciitis are mostly
adults or the elderly [1,13], neonatal MRSA necrotizing fasci-
itis has been noted recently in Taiwan [14] and the USA
[15,16]. In the latter cases, the causative agents were com-
munity-acquired MRSA (USA300 clone) with the PVL gene.
To the best of our knowledge, this study demonstrates
the ﬁrst fatal case of necrotizing fasciitis with sepsis and DIC
in an ELBW infant. The causative agent was the pandemic
New York/Japan clone (PVL-negative hospital-acquired
MRSA), indicating that PVL is not essential for the pathogen-
esis of necrotizing fasciitis. SEs are superantigens [17]. The
isolated MRSA (strain NN33) carried genes for a high-level
TABLE 1. Characteristics of MRSA strain NN33 and comparison with the Japanese and US type strains of the New York/Japan
clone
Type, virulence gene, or drug resistance
Japanese type US type
Strain NN33 Strain Mu50 Strain BK2464a
Type
ST 5 5 5
spab 387c (t653) 2d (t002) 2d (t002)
agr 2 2 2
SCCmec type II II II
Coagulase type II II II
Virulence gene
Leukocidin
lukE-lukD + + +
lukPVSF, lukM ) ) )
Haemolysin
hla, hlg, hlg-v + + +
hld + + +
hlb ())e ())e ())e
Enterotoxin
SaPIm1/n1 (tst, sec, sel) + + )
egc (seg, sei, sem, sen, seo) + + +
sep + )f(+)f,g +
sea ) +f())f,g )
sed, sej ) ) )
seb, see, seh, sek, seq, seu ) ) )
Exfoliative toxin
eta, etb, etd ) ) )
Adhesin
c12agh + + +
cna, bbp ) ) )
Drug resistance K, T, Mi, E, C, L, F G, K, Vi, T, Mi, E, C, L, F, R (K, E, C)g E, C, L, Tr
G, gentamicin; K, kanamycin; V, vancomycin; T, tetracycline; M, minocycline; E, erythromycin; C, clindamycin; L, levoﬂoxacin; F, fosfomycin; Tr, trimethoprim; R, rifampicin.
aStrain BK2464 was kindly provided by H. de Lencastre [8].
bspa-types from the Ridom Spa Server are shown in parentheses.
cThe repeat succession for spa387: T1M1G1M1K1.
dThe repeat succession for spa2: T1J1M1B1M1D1M1G1M1K1.
eSplit hlb gene due to insertion of a phage [9].
fWhen 11 strains, including strains Mu50 (from a surgical wound infection) and N315 (from a pharyngeal infection), whose genome sequences were determined [9], two iso-
lates from toxic shock syndrome (TSS), and seven isolates from neonatal TSS-like exanthematous disease (NTED) [10], were examined, one of 11 was positive for sep, and
three of 11 were positive for sea, indicating that positive cases are rare.
gThe data of Japanese type strain N315 were the same as those of Mu50, except the data shown in parentheses.
hc12ag, core 12 adhesin genes shared by all strains: icaA, icaD (for bioﬁlm formation); eno (for laminin-adhesin); fnbA, fnbB (for ﬁbronectin-adhesin); ebpS (for elastinadhesin);
clfA, clfB, ﬁb, sdrC, sdrD, sdrE (for ﬁbrinogen) [11].
iUnderlining indicates intermediate resistance.
CMI Research Notes 291
ª2009 The Authors
Journal Compilation ª2009 European Society of Clinical Microbiology and Infectious Diseases, CMI, 16, 287–301
combination of SEs (nine SEs coded for by SaPIm1/n1 [18],
egc [19], and sep). Among those, TSST-1 may suppress the
mobility of polymorphonuclear neutrophils to infection sites
[18], allowing MRSA to invade tissues. Moreover, since Spa
protein binds to the tumour necrosis factor-a receptor of
tissue cells [20], Spa protein, with a shorter stem, of strain
NN33 (spa387) may allow MRSA to get closer to and dam-
age tissue cells effectively.
In addition to the prematurity (i.e. ELBW) of the patient
as a risk factor, a high-level combination of SEs (including
TSST-1), together with adhesins and Spa (spa387 variant),
could have contributed to the pathogenesis of fatal necrotiz-
ing fasciitis with sepsis and DIC.
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